Improving pharmaceutical logistics cool-chain – Part 4

A case for improving pharmaceutical logistics cool-chain

The pharmaceutical industry often talks about improving the pharmaceutical logistics cool-chain performance and efficiency. You then hear the terms ‘partnering’, ‘collaborative working’ and ‘integrated supply chain’. We want to share with you an informative Consultation Paper. Written by Alan Kennedy, it’s called “Medicine or snake oil? – A case for reform of the pharmaceutical logistics cool-chain”. It presents the case for genuine team-work in this segment of the industry. The discussion paper debates the needs for reform in pharmaceutical logistics practice and explores the need for new relationships between stakeholders.

Week 4: A Blueprint for Action – The First Steps

There are two basic types of Integrated Pharma-Logistics Network:

1. Inclusive Network: one that includes (and is usually formed at the instigation of) a major client i.e. a pharma shipper.

2. Exclusive Network: one that is conceived by, and consists of, a group of like-minded suppliers that have come together and developed a joined up logistics offering which they can then take to shippers.

Week 5 Coming Soon – Why Big Pharma must take a lead

Please remember AmSafe Bridport can help in improving pharmaceutical logistics cool-chain. It offers a range of thermal cover solutions from single use covers to a re-usable thermal blanket. All its thermal blankets and covers meet aviation flammability requirements in accordance to FAR/JAR/CS25.853(a).Please click here for more information. Alternatively visit our contact page.

Logistics cool-chain

Latest Blog Posts